Continuous Glucose Monitor Benefits All Ages With Diabetes

Medscape August 28, 2024
Miriam E. Tucker

TOPLINE:

Use of the intermittently scanned continuous glucose monitor Freestyle Libre (FSL) was associated with improved glycaemic outcomes across all age groups. Individualised targets may be needed to improve time below range (TBR) in those older than 65 years.

METHODOLOGY:

• Examination of Libreview account data for 947 adults aged ≤ 65 years and 114 aged > 65 years with type 1 or type 2 diabetes who had been using the FSL for > 6 months.

TAKEAWAY:

• In both groups, similar proportions of patients achieved the time in range (TIR) target of > 70% (23.2% for ≤ 65 years vs 23.0% for < 65 years) and target of > 50% (63.0% vs 69.0% for ≤ 65 years and...

Today's Sponsors

Today's Sponsor